2004
DOI: 10.1016/j.dnarep.2003.10.005
|View full text |Cite
|
Sign up to set email alerts
|

Functional and physical interactions between ERCC1 and MSH2 complexes for resistance to cis-diamminedichloroplatinum(II) in mammalian cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
47
0

Year Published

2005
2005
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 51 publications
(50 citation statements)
references
References 44 publications
3
47
0
Order By: Relevance
“…We have also shown that the recognition step by MutS␤ is stimulated by PCNA. Consistent with these biochemical findings, it has been shown that Msh2 and Ercc1-Xpf act cooperatively in human cells to remove cisplatin ICLs and that these proteins interact as determined by co-immunoprecipitation experiments (22). Furthermore, recent findings in budding yeast have implicated a role for Msh2 and Exo I in repair of nitrogen mustard ICLs (23).…”
supporting
confidence: 66%
“…We have also shown that the recognition step by MutS␤ is stimulated by PCNA. Consistent with these biochemical findings, it has been shown that Msh2 and Ercc1-Xpf act cooperatively in human cells to remove cisplatin ICLs and that these proteins interact as determined by co-immunoprecipitation experiments (22). Furthermore, recent findings in budding yeast have implicated a role for Msh2 and Exo I in repair of nitrogen mustard ICLs (23).…”
supporting
confidence: 66%
“…A clear role for ERCC1-XPF in the uncoupling step has been established both in vitro and in vivo [20,21,25,[28][29][30][31], however, it is unlikely that this complex can carry out this step without the assistance of additional factors. We previously showed a requirement for the mismatch repair factor MutSβ in the early stage of ICL processing using an in vitro assay termed CRS (for cross-link induced repair synthesis) [21], and several other reports have demonstrated a role for mismatch repair components in ICL removal in vivo [26,27,32,33]. In addition, MSH2 and ERCC1-XPF have been shown to interact by co-IP experiments [26].…”
Section: Discussionmentioning
confidence: 95%
“…We previously showed a requirement for the mismatch repair factor MutSβ in the early stage of ICL processing using an in vitro assay termed CRS (for cross-link induced repair synthesis) [21], and several other reports have demonstrated a role for mismatch repair components in ICL removal in vivo [26,27,32,33]. In addition, MSH2 and ERCC1-XPF have been shown to interact by co-IP experiments [26]. We have also shown an involvement of RPA, WRN, and a four protein complex composed of PRP19/PSO4, CDC5L, SPF27, and PLRG1 in ICL repair processing using the CRS assay mentioned above [34].…”
Section: Discussionmentioning
confidence: 96%
See 1 more Smart Citation
“…73,74 Furthermore, XPF interacts with the FANC-A, Msh2, and non-erythroid α Spectrin αSPIIΣ proteins, further demonstrating its role in the removal of interstrand crosslinks. [75][76][77][78] A recently identified interesting role for XPF is its interaction with the telomere elongation factor TRF2. This factor is responsible for the conversion of telomeric TTAGGG repeats tracts to T-loop structures that protect the telomeres from inadvertent double-strand break repair.…”
Section: Cutting It Out: Xpg and Xpfmentioning
confidence: 99%